Status:
COMPLETED
Forecasting and Preventing Post-Bariatric Hypoglycaemia WP 2
Lead Sponsor:
Lia Bally
Collaborating Sponsors:
University of Padova
Conditions:
Post-bariatric Hypoglycaemia
Roux-en-Y Gastric Bypass
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
The overall aim of this study is to develop a sustainable hypoglycemia correction strategy.
Detailed Description
Obesity is a major global public health concern, for which the most effective therapy is bariatric surgery. Beyond weight loss, bariatric surgery exerts powerful effects on glucose metabolism, achievi...
Eligibility Criteria
Inclusion
- Post-bariatric surgery patients (Roux-en-Y gastric bypass) with PBH, defined as postprandial plasma or sensor glucose \<3.0 mmol/L according to the International Hypoglycaemia Study Group and exclusion of other causes of hypoglycaemia
- Age ≥18 years
Exclusion
- Inability to give informed consent as documented by signature
- Pregnant or lactating women
- Inability or contraindications to undergo the investigated intervention
- Drugs interfering with blood glucose (e.g. SGLT-2 inhibitors, acarbose) during the time of investigation
- Inability to follow the procedures of the study, e.g. due to language problems, psychological disorders, dementia, etc.
Key Trial Info
Start Date :
January 18 2022
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
July 26 2022
Estimated Enrollment :
8 Patients enrolled
Trial Details
Trial ID
NCT05250271
Start Date
January 18 2022
End Date
July 26 2022
Last Update
December 7 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Department of Diabetes, Endocrinology, Nutritional Medicine and Metabolism (UDEM), Inselspital, Bern University Hospital
Bern, Canton of Bern, Switzerland, 3010